Researchers at the University of Virginia, in collaboration with Manchester, UK-based APIS Assay Technologies Ltd., have discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase is detectable in non-invasive prostate cancer patient samples.
While doing somewhat-routine reporting on this year’s Senate Appropriations Committee bills, Paul Goldberg, editor and publisher of The Cancer Letter, quickly realized that he was seeing a full bipartisan rejection of President Donald J. Trump’s plan to defund and therefore dismantle biomedical research in the United States.
